The two-day event track unites 550+ attendees, including in-house IP counsel, private practice experts, judges and policymakers, and provides a dedicated forum for exploring the latest developments and most pressing strategic questions defining global life science patent litigation right now.

Through formats ranging from panel discussions, judicial interviews and focused roundtable conversations to quick-fire presentations and brand-new interactive workshops, the 2027 edition of Pharma & Biotech Patent Litigation Europe covers a comprehensive range of topics.

1. Access to all corners of the life science ecosystem: With a 45% in-house counsel audience representing the full spectrum of innovator, biotech, generic, biosimilar, medical device and science-driven organisations, the event provides a rare opportunity to meet and exchange perspectives with industry peers across the sector. 
2. Hear expert perspectives on the patent litigation issues that matter most: From treatment-related secondary patent litigation and process patent enforcement to SPCs, biosimilars and innovator-vs-innovator disputes, stay up-to-date as new decisions continue to shape life science IP and broader legal strategy.
3. Receive multi-jurisdictional judicial insights from across the life sciences sector: Hear directly from judges at the UPC and leading national courts as they discuss procedural developments, emerging trends and the practical considerations influencing outcomes in complex patent disputes across the sector.
4. Benefit from strategic discussions that move beyond the case law: Explore how leading in-house and external life science IP counsel are addressing the issues set to define life science patent litigation in 2027.
5. Gain a truly international perspective: With jurisdictions including the Netherlands, Germany, the UK, Poland, the U.S., Canada, Brazil, India and China all represented on the programme, build an integrated, up-to-date view of the most pressing challenges and latest developments shaping global life science patent disputes.
6. Meet all the key stakeholders shaping life sciences patent strategy in one place: The event unites senior in-house counsel who instruct law firms and allocate external legal spend with private practice litigators, judges, policymakers, regulators, consultants and solution providers from across the sector.